Shares of Synergy Pharmaceuticals (SGYP) rose 10% to $4.00 in Friday trading. On Thursday, Cantor Fitzgerald started coverage of the New York firm's shares with an overweight rating and an $11 price target.

Shares of Bluebird Bio (BLUE)  gained 6.3% to $84.15 on the heels of an upgrade to buy from hold by analysts at Maxim Group. In a note on Friday, the analysts said they believe that the event that could "break BLUE shares out of the current valuation range is bb2121 CAR-T data in multiple myeloma" that will be presented at the American Society of Clinical Oncology's annual meeting. The conference takes place June 2 - 6 in Chicago.

Among the other biotech movers was DBV Technologies (DBVT) . The Bagneux, France-based firm's American depository shares were up 2.2% to $34.90.

Jim Cramer and the AAP team explain why they have downgraded HP Enterprise's (HPE) stock to Two from One. Find out what they are telling their investment club members. Get a free trial subscription to Action Alerts PLUS.

Meanwhile, over on Real Money, Cramer discusses why Lululemon's (LULU) stock made him waver. Get his insights or analysis with a free trial subscription to Real Money.

Click here for the latest business headlines.

Editor's Pick: Originally published June 2.

More from Health

How to Invest in Cannabis - In Its Many Forms

How to Invest in Cannabis - In Its Many Forms

Eli Lilly, AstraZeneca Shares Fall After Halting Alzheimer's Drug Test

Eli Lilly, AstraZeneca Shares Fall After Halting Alzheimer's Drug Test

There's Nothing Funny About Guardianship

There's Nothing Funny About Guardianship

White House Economic Adviser Larry Kudlow in Good Condition After Heart Attack

White House Economic Adviser Larry Kudlow in Good Condition After Heart Attack

Can Legal Cannabis Help Slow the Opioid Drug Epidemic in the U.S.?

Can Legal Cannabis Help Slow the Opioid Drug Epidemic in the U.S.?